The FDA is currently conducting a review of mifepristone, one of the most commonly prescribed forms of medication abortion, ...

And just a few moments ago, the Fifth Circuit panel granted a stay in Louisiana's challenge to the mifepristone telemedicine approval from 2023. What, you thought the case was over after Alliance for ...

A Fifth Circuit panel appeared fractured on whether the Trump administration violated detained noncitizens’ due-process ...